Get the Stockscreener App
2.63
3.54%
0.09
After Hours:
2.58
-0.05
-1.90%
Aixcrypto Holdings Inc stock is traded at $2.63, with a volume of 87,390.
It is up +3.54% in the last 24 hours and up +0.00% over the past month.
AIxCrypto Holdings Inc is a Web3-driven decentralized artificial intelligence technology platform.
See More
Previous Close:
$2.54
Open:
$2.425
24h Volume:
87,390
Relative Volume:
6.72
Market Cap:
$13.57M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.14%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$2.35
$2.65
1-Week Range:
$2.26
$2.65
52-Week Range:
$2.26
$2.77
Aixcrypto Holdings Inc Stock (AIXC) Company Profile
Name
Aixcrypto Holdings Inc
Sector
Industry
Phone
(760) 918-9165
Address
2042 CORTE DEL NOGAL, CALIFORNIA
Compare AIXC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AIXC
Aixcrypto Holdings Inc
|
2.63 | 13.11M | 0 | 0 | 0 | 0.00 |
|
MSFT
Microsoft Corporation
|
479.93 | 3.55T | 293.81B | 104.91B | 78.02B | 14.06 |
|
ORCL
Oracle Corp
|
214.33 | 592.20B | 59.02B | 12.63B | -5.88B | 4.3198 |
|
PLTR
Palantir Technologies Inc
|
177.75 | 419.68B | 3.90B | 1.10B | 1.79B | 0.4275 |
|
CRWD
Crowdstrike Holdings Inc
|
512.55 | 131.54B | 4.34B | -298.19M | 1.04B | -1.1966 |
|
SNPS
Synopsys Inc
|
463.45 | 88.89B | 6.43B | 1.15B | 1.30B | 12.77 |
Aixcrypto Holdings Inc Stock (AIXC) Latest News
An analyst sees good growth prospects for AIxCrypto Holdings Inc (AIXC) - Setenews
AIxCrypto Rebrands and Begins Trading Under New Ticker AIXC, Advancing Its 'Three Driving Forces' Strategy to Become the No. 1 Gateway to AI Web3 and Bridge Between Web2 and Web3 - Reuters
What's Going On With Faraday Future Stock Monday? - Sahm
Faraday Future (NASDAQ: FFAI) FX Super One Parts Reach Long Beach, Enter Pilot Build - Stock Titan
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Completes its “Dual Flywheel, Dual Bridge, and Dual Listed-Company” Structure; First batch of FX Super One Complete Sets of Components to Arrive at Port of Long Beach Next Week - GlobeNewswire Inc.
AIxCrypto Holdings Regains Nasdaq Compliance After Issue - The Globe and Mail
AIxCrypto Holdings Rebrands, Unveils New Strategy - The Globe and Mail
AIxCrypto Holdings, Inc. Rebrands and Launches New Strategy - TradingView
AIxCrypto Rebrands as AIxCrypto Holdings, Inc., Unveils Bold Web3 Strategy - Bitget
QUALIGEN THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - MarketScreener
Faraday Future Advances Dual-Listed Framework with AIxCrypto Holdings Inc. Name Change and Strategic Initiatives - Quiver Quantitative
Faraday Future Completes Formation of "FFAI+AIXC" Dual-Flywheel, Dual-Bridge, and Dual-Listed Company System; Its Majority Owned Crypto Company Renamed as AIxCrypto (Nasdaq: AIXC) - Nasdaq
Aixcrypto Holdings Inc appoints Jie Sheng as chairman of boardSEC filing - MarketScreener
AIxCrypto rebrands from Qualigen, unveils three-part strategy By Investing.com - Investing.com Nigeria
AIxCrypto rebrands, begins trading under ‘AIXC’ ticker - TipRanks
Qualigen Therapeutics Rebrands to AIxCrypto Holdings - MSN
AIxCrypto Rebrands and Begins Trading Under New Ticker AIXC, Advancing Its "Three Driving Forces" Strategy to Become the No.1 Gateway to AI Web3 and a Bridge Between Web2 and Web3 - The AI Journal
Jia Yueting-backed listed company QLGN has been renamed AIxCrypto and will launch stock tokenization business - Bitget
Qualigen Therapeutics, Inc. will Change its Name to AIxCrypto Holdings, Inc - MarketScreener
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: On November 20, QLGN, which is Strategically Invested in and Controlled by FFAI, will Begin Using its New Name, AIxCrypto, and will be Traded Under AIXC - The Manila Times
Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy - Investing News Network
Faraday Future Becomes Majority Shareholder in Qualigen Therapeutics, Preparing for Corporate Rebranding and Strategic Transformation on November 20 - Quiver Quantitative
Qualigen (NASDAQ: QLGN) to Rebrand as AIxCrypto, Launch AI × Web3 Strategy Nov. 20 - Stock Titan
"Biotech-to-DeAI Transformation: AIxCrypto Rises as the Portal to the Web3 Age" - Bitget
QLGN to Become AIxCrypto as Faraday Future (NASDAQ: FFAI) Takes Control, AIXC Ticker - Stock Titan
Qualigen Therapeutics Inc. Announces Rebranding to AIxCrypto and Launch of Web3 Initiatives - Quiver Quantitative
Qualigen Therapeutics to Rebrand as AIxCrypto After - GlobeNewswire
Qualigen (NASDAQ: QLGN) chooses BitGo for $30M C10 treasury in top 10 crypto basket - Stock Titan
$16B Liquidated in Crypto Sell-Off — Qualigen Launches C10 Treasury Buying Program Next Week - Stock Titan
Co-CEO Jerry Wang & CFO Koti Meka join Qualigen; Board adds 3 directors and auditor switches to MGO for FY2025 - Stock Titan
$41M Crypto Transformation: Qualigen Partners with EV Giant Faraday Future for Web3 Evolution to CXC10 - Stock Titan
$41M Strategic Investment: EV Maker Faraday Future Pivots to Crypto with Majority Stake in Qualigen - Stock Titan
Qualigen Secures Nasdaq Listing Status with $4.5M Strategic Funding, Addresses All Compliance Issues - Stock Titan
Qualigen's Cancer Treatment Patent Portfolio Expands to 25 Countries, Protection Until 2040 - Stock Titan
Qualigen Therapeutics, Inc. Appoints Robert B. Lim to Serve as Chair of the Audit Committee of the Board - MarketScreener
Nasdaq Threatens to Delist Qualigen on May 5: Company Plans Last-Minute Appeal - Stock Titan
Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - MarketScreener
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares - MarketScreener
Qualigen Therapeutics, Inc. Appoints Graydon Bensler as an Independent Member - MarketScreener
Qualigen Therapeutics : Shares Expected to Begin Trading on Split Adjusted Basis on November 5, 2024 Form 8 K - MarketScreener
Qualigen Therapeutics, Inc. Announces Chief Executive Officer Changes - MarketScreener
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - MarketScreener
Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. - MarketScreener
Qualigen Therapeutics to Seek Acquisitions - MarketScreener
Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering - MarketScreener
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination - MarketScreener
Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023 - MarketScreener
Qualigen Therapeutics, Inc. Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors - MarketScreener
Qualigen Therapeutics Announces US FDA IND Clearance to Initiate Phase 1 Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors - MarketScreener
Qualigen Therapeutics, Inc. Announces the Resignation of Amy Broidrick as President, Chief Strategy and Operating Officer and A Director, Effective June 16, 2023 - MarketScreener
QUALIGEN THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) - MarketScreener
Aixcrypto Holdings Inc Stock (AIXC) Financials Data
There is no financial data for Aixcrypto Holdings Inc (AIXC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.77%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):